Skip to content

Clinical trials

Phase 1/2 Ovarian Neoplasms trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Phase: Phase 1/2 Country / region: Spain Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20111
20122
20142
20151
20162
20173
20181
20192
20206
20217
20221
20234
20243
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting19
Completed10
Terminated4
Active, not recruiting3
Unknown status2
Suspended1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca5
BicycleTx Limited2
Genmab2
Incyte Biosciences International Sàrl2
Regeneron Pharmaceuticals2
AbbVie (prior sponsor, Abbott)1
Aprea Therapeutics1
Artios Pharma Ltd1
BioInvent International AB1
BioNTech SE1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms40
Endometrial Neoplasms20
Carcinoma, Non-Small-Cell Lung13
Breast Neoplasms12
Colorectal Neoplasms10
Fallopian Tube Neoplasms10
Triple Negative Breast Neoplasms10
Uterine Cervical Neoplasms9
Melanoma8
Squamous Cell Carcinoma of Head and Neck8

Trials

Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.